CervoMed

CRVO • NASDAQ • Stock Fundamentals

CervoMed is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John J. Alam, with a market cap of $28.2M.

Market Cap$28.2M

Employees8.0

CEOJohn J. Alam

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 18, 2026 · 10 days agoQ1 2026

Next EarningsAug 14, 2026 · in 3 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about CervoMed

CervoMed (CRVO) has a market capitalization of $28.2M and trades on NASDAQ.

CervoMed has approximately 8 employees.